News from viewray, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 10, 2022, 06:30 ET Clinical Value of MRIdian® MRI-Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022

ViewRay, Inc. (Nasdaq: VRAY) announced today the results of a study presented at the Annual Meeting of the European Society for Radiotherapy and...

May 06, 2022, 00:01 ET MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of ...

May 05, 2022, 16:01 ET ViewRay Announces First Quarter 2022 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2022. First Quarter 2022...

May 03, 2022, 06:30 ET UCI Health Adopts ViewRay® MRIdian® MRI-Guided Radiation Therapy System

ViewRay, Inc. (NASDAQ: VRAY) today announced that UCI Health has purchased a MRIdian MRI-guided radiation therapy system for its new Chao Family...

Apr 21, 2022, 08:30 ET ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2022 financial results. ViewRay will hold a...

Mar 15, 2022, 06:30 ET University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy

ViewRay, Inc. (NASDAQ: VRAY) today announced that University Hospital Agostino Gemelli has surpassed the treatment of 1,000 patients using the...

Mar 10, 2022, 12:00 ET ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will host a Virtual Clinical Data Event for Investors and Analysts on Wednesday, March...

Mar 10, 2022, 06:30 ET First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer

ViewRay, Inc. (NASDAQ: VRAY) today announced the first toxicity results from the prospective single-arm Phase II SCIMITAR trial. A secondary analysis ...

Mar 09, 2022, 16:01 ET ViewRay Enters into Cooperation Agreement with Hudson Executive Capital

ViewRay, Inc. (NASDAQ: VRAY) today announced that it has reached an agreement with Hudson Executive Capital LP ("HEC") to appoint Susan Schnabel to...

Mar 03, 2022, 06:30 ET Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul

ViewRay, Inc. (NASDAQ: VRAY) today announced that the Acibadem Group, one of the leading private healthcare service institutions in Turkey, has...

Feb 24, 2022, 16:01 ET ViewRay Announces Fourth Quarter and Full Year 2021 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the fourth quarter and full fiscal year ended December 31, 2021....

Feb 15, 2022, 06:30 ET Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

ViewRay, Inc. (NASDAQ: VRAY) today announced that interim data from the single center Phase III randomized MIRAGE trial, led by UCLA, comparing...

Feb 10, 2022, 08:00 ET ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2021 financial results. ViewRay will ...

Feb 10, 2022, 08:00 ET ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools...

Feb 09, 2022, 06:30 ET University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services

ViewRay, Inc. (NASDAQ: VRAY) today announced that the University Hospital Halle (Saale) in Germany has purchased a MRIdian MRI-guided radiation...

Jan 25, 2022, 07:00 ET ViewRay® to Participate in the B. Riley Securities Oncology Conference

ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the B. Riley Securities Oncology Conference. Scott Drake, President ...

Jan 10, 2022, 08:49 ET ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended December ...

Dec 23, 2021, 16:15 ET ViewRay to Participate in the 40th Annual J.P. Morgan Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. ViewRay's management is...

Dec 15, 2021, 06:30 ET ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features

ViewRay, Inc. (NASDAQ: VRAY) today announced that the company received FDA 510(k) clearance for its next generation of MRI-guided radiation therapy...

Dec 07, 2021, 06:30 ET Northside Hospital Chooses MRIdian System to Expand Advanced Radiation Therapy Treatment Services

ViewRay, Inc. (NASDAQ: VRAY) today announced that Northside Hospital in Georgia has selected MRIdian MRI-guided radiation therapy system to expand...

Nov 24, 2021, 06:30 ET ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide

ViewRay, Inc. (NASDAQ: VRAY) today announced, in recognition of Pancreatic Cancer Awareness Month, more than 2,300 pancreatic cancer patients have...

Nov 23, 2021, 11:30 ET ViewRay Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in connection with Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer...

Nov 19, 2021, 11:53 ET ViewRay Announces Closing of Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer...

Nov 16, 2021, 22:16 ET ViewRay Announces Pricing of Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer...

Nov 16, 2021, 16:05 ET ViewRay Announces Proposed Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer...